MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease

KO. Ohta, TN. Nakajima (Kashiwazaki, Japan)

Meeting: 2019 International Congress

Abstract Number: 1944

Keywords: Bradykinesia, Cognitive dysfunction

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To compare the metabolism of the putamen and the cerebral cortex between the akinesia-dominant group and the tremor-dominant group of Parkinson’s disease (PD) patients.

Background: Cognitive dysfunction is more likely to occur in patients with rigid-akinetic PD than in tremor-dominant PD patients. Furthermore, dopamine transporter (DAT) imaging has been reported as a biomarker of cognitive dysfunction in PD patients.

Method: We surveyed the data pertaining to cases with PD reported in our hospital in 2017. We determined the main symptom of the PD patients via inquiring the patients and their caregivers and their neurological findings. For the analysis of the DAT scan data, ROI setting, SBR (Specific Binding Ratio) evaluation, and QSPECT package were used. Blood flow in the cerebral cortex of both the groups was measured with 131I-IMP SPECT, which was compared using 2tZ software.

Results: There were 125 patients with Parkinson’s disease, among which 67 patients were taking DAT scan. Among the 38 PD patients who were selected, there were 26 tremor-dominant PD patients and 12 akinesia-dominant patients. There was no significant difference in the disease duration between the two groups. However, the incidence of cognitive dysfunction was slightly higher in the akinesia-dominant group. But it was no significant difference between the two groups. The akinesia-dominant group showed a significantly lower value of average SBR in DAT imaging than that of the tremor-dominant group (1.56 versus 2.38). In 131I-IMP SPECT, the akinesia group showed a decrease in blood flow around the pre-supplementary motor cortex compared to the tremor-dominant group.

Conclusion: In the akinesia-dominant group, the decline in the putamen function was severer than that in the tremor-dominant group, as shown by DAP imaging. We believe that the decrease in blood flow in the pre-supplementary motor cortex is related to the putamen condition that may vary between the tremor-dominant and the akinesia-dominant groups. This further suggests a difference in the range of dysfunction between the two groups, which may be related to the difference in progression of PD.

To cite this abstract in AMA style:

KO. Ohta, TN. Nakajima. Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuroradiological-differences-between-patients-with-akinesia-dominant-and-tremor-dominant-parkinsons-disease/. Accessed June 23, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroradiological-differences-between-patients-with-akinesia-dominant-and-tremor-dominant-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley